The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

A major cardiovascular risk factor is thickening of the heart walls (hypertrophy), which can result from high blood ...

AliveGen USA Inc. (AliveGen), a clinical-stage biopharmaceutical company, today announced new preclinical data demonstrating that its investigational therapy ALG-801 delivered superior efficacy ...

Guidelines regarding the management of patients with valvular heart disease have been published by the European Society of Cardiology and EACTS.

Cardiovascular aging is a major contributor to the global burden of heart disease, characterized by structural remodeling, metabolic alterations, and a ...

Danicamtiv is an investigational selective agonist of cardiac myosin, intended to help myocyte contraction by enhancing cardiac myosin function and availability. As such, it is positioned as a ...

Stem cell-derived conditioned medium, the liquid that remains after cells are cultured, reduced PAH signs in rats and cells, ...

Scientists have uncovered the protective role of the protein GADD45A in guarding the heart from harmful stress responses. When the heart is placed under greater strain, its ventricular wall can ...

Atrial fibrillation (AF) is the most common sustained arrhythmia, with a rising global burden. While previous studies have ...

Through a comprehensive approach combining transcriptomic profiling, histological analysis, and functional validation in organoid and animal models, a research team led by Associate Professor ...

Cancer cachexia is a complex metabolic syndrome characterized by the ongoing loss of skeletal muscle mass, with or without fat loss, that cannot be reversed entirely by conventional nutritional ...